CompletedNot Applicable

Thoracoscopic Mesh Repair of Diaphragmatic Defects for Hepatic Hydrothorax

63 participantsStarted 2005-01

Plain-language summary

The management of refractory hepatic hydrothorax is challenging and usually unsuccessful. The study will discuss the perioperative treatment, effectiveness, and morphology of diaphragmatic defects of hepatic hydrothorax in thoracoscopic mesh repair. Risk factors associated with increased three-month mortality in these critically ill patients will be studied.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients with refractory hepatic hydrothorax (\> 3 times thoracentesis and failure to maximal doses of diuretics) Exclusion Criteria: * Patients with systemic bacteremia, positive culture of bacteria of pleural effusion or ascites were excluded from the study because of potential mesh contamination.

What they're measuring

one-month mortality

Timeframe: one month

three-month mortality

Timeframe: three month

Trial details

NCT IDNCT02508688

SponsorNational Taiwan University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-12

View on ClinicalTrials.gov More Liver Cirrhosis trials